-
ICD-10-CM Codes
›
-
D50-D89
›
-
D70-D77
›
-
D72-
›
-
2023 ICD-10-CM Diagnosis Code D72
2023 ICD-10-CM Diagnosis Code D72
Other disorders of white blood cells
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
- D72 should not be used for reimbursement purposes as there are multiple codes below it that contain a greater level of detail.
- The 2023 edition of ICD-10-CM D72 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D72 - other international versions of ICD-10 D72 may differ.
Type 1 ExcludesType 1 Excludes Help
A type 1 excludes note is a pure excludes. It means "not coded here". A type 1 excludes note indicates that the code excluded should never be used at the same time as D72. A type 1 excludes note is for used for when two conditions cannot occur together, such as a congenital form versus an acquired form of the same condition.
- basophilia (
ICD-10-CM Diagnosis Code D72.824
Basophilia
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
- immunity disorders (D80-D89
ICD-10-CM Range D80-D89
Certain disorders involving the immune mechanismIncludes- defects in the complement system
- immunodeficiency disorders, except human immunodeficiency virus [HIV] disease
- sarcoidosis
Type 1 Excludes- autoimmune disease (systemic) NOS (M35.9)
- functional disorders of polymorphonuclear neutrophils (D71)
- human immunodeficiency virus [HIV] disease (B20)
- D80 Immunodeficiency with predominantly anti...
- D81 Combined immunodeficiencies
- D82 Immunodeficiency associated with other m...
- D83 Common variable immunodeficiency
- D84 Other immunodeficiencies
- D86 Sarcoidosis
- D89 Other disorders involving the immune mec...
- neutropenia (
ICD-10-CM Diagnosis Code D70
Neutropenia
2016 2017 2018 2019 2020 2021 2022 2023 Non-Billable/Non-Specific Code
Includes- agranulocytosis
- decreased absolute neurophile count (ANC)
Type 1 Excludes- neutropenic splenomegaly (D73.81)
- transient neonatal neutropenia (P61.5)
- preleukemia (syndrome) (
ICD-10-CM Diagnosis Code D46.9
Myelodysplastic syndrome, unspecified
2016 2017 2018 2019 2020 2021 2022 2023 Billable/Specific Code
The following code(s) above
D72 contain annotation back-references
Annotation Back-References
In this context, annotation back-references refer to codes that contain:
- Applicable To annotations, or
- Code Also annotations, or
- Code First annotations, or
- Excludes1 annotations, or
- Excludes2 annotations, or
- Includes annotations, or
- Note annotations, or
- Use Additional annotations
that may be applicable to
D72:
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
ICD-10-CM Codes Adjacent To D72
D69.9 Hemorrhagic condition, unspecified
D70.0 Congenital agranulocytosis
D70.1 Agranulocytosis secondary to cancer chemotherapy
D70.2 Other drug-induced agranulocytosis
D70.3 Neutropenia due to infection
D70.9 Neutropenia, unspecified
D71 Functional disorders of polymorphonuclear neutrophils
D72
Other disorders of white blood cells
D72.0 Genetic anomalies of leukocytes
D72.11 Hypereosinophilic syndrome [HES]
D72.110 Idiopathic hypereosinophilic syndrome [IHES]
D72.111 Lymphocytic Variant Hypereosinophilic Syndrome [LHES]
D72.118 Other hypereosinophilic syndrome
D72.12 Drug rash with eosinophilia and systemic symptoms syndrome
D72.18 …… in diseases classified elsewhere
Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.
